The diagnostic evaluation of a patient with hypercortisolism should progress through screening and then confirmatory hormonal measurements. However, tests of the hypothalamic-pituitary-adrenal axis to predict the cause of hypercortisolism always should be viewed as providing supportive data, as exceptions that occur limit the usefulness of these tests. Familiarity with the diagnostic errors of the procedures is essential.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Adrenocortical carcinoma: a practical guide for clinicians.
Lancet Diabetes Endocrinol
March 2025
Department of Clinical and Biological Sciences, Internal Medicine, San Luigi Hospital, University of Turin, Turin, Italy.
Adrenocortical carcinoma is a rare endocrine malignancy. The management of patients with adrenocortical carcinoma is challenging for several reasons, including its heterogeneous but frequently aggressive biological behaviour; tumour-related hormonal excess (eg, Cushing's syndrome or virilisation); the overall paucity of evidence regarding diagnostic investigation and treatment; the approval of only one drug (mitotane); and the scarcity of centres with sufficient experience. In this Review, we present 25 questions on the most important aspects of the clinical management of adult patients with adrenocortical carcinoma that we have frequently asked ourselves over the past 25 years.
View Article and Find Full Text PDFThe value of targeted CXCR4 F-AlF-NOTA-pentixafor PET/CT for subtyping primary aldosteronism.
Front Endocrinol (Lausanne)
March 2025
Department of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Objective: The study aimed to investigate the diagnostic value of F-AlF-NOTA-Pentixafor PET/CT in subtyping primary aldosteronism (PA).
Methods: This study enrolled 88 patients with PA or nonfunctional adenoma (NFA) for F-Pentixafor PET/CT scan. Of these, 20 patients underwent adrenal venous sampling (AVS), and 65 underwent adrenalectomy and postoperative follow-up.
Endocrine paraneoplastic syndromes in lung cancer: A call for clinical vigilance (Review).
Mol Clin Oncol
April 2025
Department of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Endocrine paraneoplastic syndromes (PNS) are uncommon but clinically impactful manifestations associated with malignancies, particularly lung cancer, most notably small-cell lung cancer. These syndromes arise from ectopic hormone production by malignant cells, causing systemic effects that are independent of direct tumor invasion or metastasis. Their presentation often precedes or signals recurrence of the primary cancer, underscoring the importance of early recognition and targeted intervention.
View Article and Find Full Text PDFPrevalence of Metabolic-Associated Steatotic Liver Disease in Patients With Primary Aldosteronism.
Clin Endocrinol (Oxf)
March 2025
Department of Medicine DIMED, Endocrine Unit, Padua, Italy.
Objective: To assess the prevalence of metabolic associated steatotic liver disease (MASLD) in patients with primary aldosteronism (PA) compared to benign adrenal adenomas, and to evaluate the impact of hormonal excess in inducing MASLD.
Design: Single-centre retrospective study.
Methods: Hepatic steatosis was assessed by liver/spleen (L/S) ratio from unenhanced abdomen computed tomography images (reference value < 1.
Case Report: Thymic neuroendocrine tumor with metastasis to the breast causing ectopic Cushing's syndrome.
Front Oncol
February 2025
Department and Clinic of Endocrinology and Internal Medicine, Wroclaw Medical University, Wroclaw, Poland.
Ectopic adrenocorticotropic hormone secretion (EAS) is responsible for approximately 10%-18% of Cushing's syndrome cases. Thymic neuroendocrine tumors (NETs) comprise 5%-16% of EAS; therefore, they are very rare and the data about this particular tumors is scarce. We present a case of a 34-year-old woman with a rapid onset of severe hypercortisolism in April 2016.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!